Trial Information
'A Multicentre, Prospective Randomized Study to Assess the Effect When GnRH Antagonist is Started Either on Stimulation Day 1 and Day 6 vs. Conventional GnRH Agonist Long Protocol in Patients With Polycystic Ovary Syndrome Undergoing IVF-ET(in Vitro Fertilization - Embryo Transfer)
Inclusion Criteria:
- PCOS patients (diagnosed as 2003 ASRM(The American Society for Reproductive
Medicine)/ESHRE(The European Society of Human Reproduction and Embryology) consensus
meeting guideline)
- age 20-40 years
- patients who have normal uterus
Exclusion Criteria:
- patients who have abnormal thyroid function
- patients who have abnormal prolactin test
- patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia,
or androgen-producing tumor.
- Patients who reject informed consent
- patients who have experience of adverse events for GnRH agonist, antagonist,
recombinant FSH(follicle-stimulating hormone).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
number of oocyte retrieved
Outcome Time Frame:
ovum pick up day, At the point of ovum pick-up, we can count how many oocyte was retrieved. So, almost just after ovum pick-up, outcome measure will be possible.
Safety Issue:
No
Authority:
Korea: Institutional Review Board
Study ID:
PCOS_IVF
NCT ID:
NCT01402336
Start Date:
June 2011
Completion Date:
December 2016
Related Keywords:
- Infertility
- Polycystic Ovary Syndrome
- Polycystic ovary syndrome
- ovulation induction
- In vitro fertilization-embryo transfer
- Infertility
- Polycystic Ovary Syndrome